Literature DB >> 20079834

Matrix biology meets toxinology.

Johannes A Eble1.   

Abstract

Venoms are cocktails containing pharmacologically active compounds, which drastically affect essential functions of the neuromuscular and cardiovascular system, as well as of blood, kidney and other organs. As the extracellular matrix and its contacts with cells are responsible for maintaining the integrity and functionality of these organs and tissues, it is not surprising that several venom components target matrix molecules and their respective cellular receptors. Many venom components, such as matrix-degrading enzymes, disintegrins, and C-type lectin-like proteins, have been identified and have laid the foundation for the frontier research field of matrix toxinology. Interestingly, many toxins consist of domains which are structurally homologous to modules and domains of matrix proteins, their proteinases and cellular receptors. In addition to finding new agents and tools, which specifically interact with matrix molecules and their receptors, the characterization of known matrix-targeting toxins will provide insights into their molecular modes of action and thus may lead to potential new therapeutic strategies for treating matrix-related diseases, such as blood clotting and thrombocyte-mediated disorders, but also tumor malignancies. Copyright 2009 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079834     DOI: 10.1016/j.matbio.2010.01.004

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  7 in total

1.  Proteome of Hydra nematocyst.

Authors:  Prakash G Balasubramanian; Anna Beckmann; Uwe Warnken; Martina Schnölzer; Andreas Schüler; Erich Bornberg-Bauer; Thomas W Holstein; Suat Ozbek
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

2.  Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Authors:  Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

Review 3.  Disintegrins from hematophagous sources.

Authors:  Teresa C F Assumpcao; José M C Ribeiro; Ivo M B Francischetti
Journal:  Toxins (Basel)       Date:  2012-04-26       Impact factor: 4.546

4.  Use of a synthetic biosensor for neutralizing activity-biased selection of monoclonal antibodies against atroxlysin-I, an hemorrhagic metalloproteinase from Bothrops atrox snake venom.

Authors:  Francisco Santos Schneider; Dung Le Nguyen; Karen Larissa Castro; Sandra Cobo; Ricardo Andrez Machado de Avila; Nivia de Assis Ferreira; Eladio Flores Sanchez; Christophe Nguyen; Claude Granier; Pascale Galéa; Carlos Chávez-Olortegui; Franck Molina
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

5.  A Collaborative Study to Establish the Second Korean National Reference Standard for Snake Venom.

Authors:  Kiwon Han; Kikyung Jung; Hokyung Oh; Hojin Song; Sangmi Park; Ji-Hye Kim; Garam Min; Byung-Hwa Lee; Hyun-Sik Nam; Yang Jin Kim; Manabu Ato; Jayoung Jeong; Chiyoung Ahn
Journal:  Toxicol Res       Date:  2018-07-15

6.  A Case of Non-Operative Management of Atraumatic Splenic Hemorrhage Due to Snakebite Venom-Induced Consumption Coagulopathy.

Authors:  Hyeong Seok Lee; Won Young Sung
Journal:  Am J Case Rep       Date:  2019-09-05

7.  Purification and characterization of BmooAi: a new toxin from Bothrops moojeni snake venom that inhibits platelet aggregation.

Authors:  Mayara Ribeiro de Queiroz; Carla Cristine N Mamede; Nadia Cristina G de Morais; Kelly Cortes Fonseca; Bruna Barbosa de Sousa; Thaís M Migliorini; Déborah Fernanda C Pereira; Leonilda Stanziola; Leonardo A Calderon; Rodrigo Simões-Silva; Andreimar Martins Soares; Fábio de Oliveira
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.